Brief: Redwood Pharma Resolves On Rights Issue Of About SEK 31.6 Mln

Redwood Pharma AB

11/07/2023 07:52

July 11 (Reuters) - Redwood Pharma AB  REDWPH.ST :
    * SAID ON MONDAY DECIDES ON RIGHTS ISSUE OF ABOUT SEK 31.6
MLN TO
FINANCE REGULATORY WORK, SCALE-UP OF PRODUCTION PRIOR TO
COMMERCIALISATION OF RP501
    * SUBSCRIPTION PRICE IS SEK 0.30 PER UNIT, CORRESPONDING TO
SEK
0.10 PER SHARE
    * RIGHTS ISSUE WILL, UPON FULL SUBSCRIPTION, PROVIDE CO WITH
ABOUT
SEK 31.6 MLN BEFORE TRANSACTION COSTS
    * RIGHTS ISSUE IS SECURED IN WRITING BY EXISTING
SHAREHOLDERS,
EXTERNAL INVESTORS TO TOTAL OF ABOUT 50% (CORRESPONDING TO ABOUT
SEK 15.8 MLN) THROUGH SUBSCRIPTION, GUARANTEE COMMITMENTS

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr1hB9vN
 Further company coverage:  REDWPH.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))